Asbestosis Treatment Market Analysis

Drugs (Salbutamol, Guaifenesin, Acetaminophen, Prednisone)

Based on drugs, the prednisone segment in the asbestosis treatment market is predicted to hold the largest revenue share of about 45% during the forecast period. Prednisone is a synthetic glucocorticoid that is used to suppress inflammation and weaken the immune system. The liver converts the prodrug prednisone into prednisolone, which is the medication's active component. Prednisone has no biological effects before its conversion to prednisolone through hepatic metabolism. Prednisone's use is expected to rise significantly throughout the forecast period as it is an anti-inflammatory that also helps reduce inflammation caused by sickness. 19,898,457 prescriptions were written in the US in 2021.

Route of Administration (Oral, Inhalation, Intravenous)

Based on the route of administration, the inhalation segment in the asbestosis treatment market is estimated to hold the largest revenue share of about 40% during the forecast period. The growth of the segment is because many people favor inhalation to swallowing tablets or pills for delivery. It has long been established that inhaling medication is an efficient way to get medication into the lungs to treat respiratory conditions. Compared to oral pills, inhaled drugs are taken directly into the airways, allowing for a smaller dose to be given and a faster onset of action as well as fewer side effects. It is anticipated that the growing incidence of respiratory conditions such as cystic fibrosis, asthma, and COPD will propel market growth. Asthma impacted almost 25 million Americans in 2021, making up 7.7% of adults and 8.4% of children in the country, according to the Centers for Disease Control and Prevention (CDC).

Our in-depth analysis of the global asbestosis treatment market includes the following segments: